In this article we will check out the progression of hedge fund sentiment towards LEAP THERAPEUTICS, INC. (NASDAQ:LPTX) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and […]...
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filings submitted by hedge funds and prominent investors. These filings show these funds' portfolio positions as of March 31st, 2020. […]...
Canopy Growth (NYSE:CGC) stock has not shown a dramatic move since its recent quarterly conference call, which laid out lackluster guidance and performance during the fourth quarter of fiscal year 2019. There are some positives from the earnings reports, though. Canopy achieved 76% revenue growth year-over-year ending March 2020, reduced cash burn and will be working aggressively to scale down their operations due to falling wholesale prices.Source: Shutterstock Chief Financial Officer Mike Lee said the company made dramatic moves to address the realities of their financial situation. They are reducing production capacity 40% in Canada by closing both their greenhouses. The company is also ended their hemp farming operation in New York, and will transition to a "asset-light model" in Columbia.Canopy is in about 15 markets, and will exit those over time. Adjusted gross margins were 42%, after excluding one-time restructuring and inventory costs. Additionally, the amount of cash they have...
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filings submitted by hedge funds and prominent investors. These filings show these funds' portfolio positions as of March 31st, 2020. […]...
With ultra-expansionary monetary policies coupled with re-opening of economies globally, stock markets have surged. The indexes in the United States have almost erased all losses incurred due to the novel coronavirus-driven economic slowdown.As bullish sentiments sustain, it makes sense to remain invested or consider fresh equity exposure. However, investors need to abstain from stocks that are trading at rich valuations. At any point of time, there are value stocks up for grabs.Let's discuss three value stocks in this column that trade at attractive valuations. These names can deliver strong returns with a medium to long-term investment horizon.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Great Biotech Stocks to Buy and Hold Now * Alibaba Group (NYSE:BABA) * Chevron Corporation (NYSE:CVX) * Qualcomm Incorporated (NASDAQ:QCOM) Value Stocks to Buy for Smart Investors: Alibaba Group (BABA)Source: BigTunaOnline / Shutterstock.com Before I talk about the growth potential for Alibaba, investors...
Investors have been looking for companies that are getting through the novel coronavirus without taking a major hit. And sure, there's value in a good high-quality defensive stock. But don't sell yourself short -- there are great opportunities to go on the offense in this market as well. For example, look at Micron (NASDAQ:MU) stock.Source: Casimiro PT / Shutterstock.com The semiconductor memory developer is shaping up to be a big beneficiary of the economic ripples that the new vius has caused. Many investors are sleeping on Micron as a social-distancing play. Micron doesn't have the flashiest products when it comes to work-from-home trends. But its offerings are essential to powering several of the current technological megatrends that are transforming American life.Micron is also under the radar because it last published earnings results on March 25 for a quarter that finished in February. Thus, it hasn't put out any quarterly results since...
